You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 4, April 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reduced Penetrance in a Brazilian Family With Spinocerebellar Ataxia Type 10

Salmo Raskin, MD, PhD; Tetsuo Ashizawa, MD; Hélio A. G. Teive, MD, PhD; Walter O. Arruda, MD, MSc; Ping Fang, PhD; Rui Gao, MD; Misti C. White, BS; Lineu C. Werneck, MD, PhD; Benjamin Roa, PhD

Arch Neurol. 2007;64(4):591-594.

Objective  To describe reduced penetrance associated with early onset in a Brazilian family with spinocerebellar ataxia type 10.

Design  Clinical examination and molecular analysis for the ATTCT repeat responsible for spinocerebellar ataxia type 10 in a patient and family members through 3 generations.

Setting  Ambulatory care.

Patients  A 28-year-old female Brazilian patient who presented with early-onset cerebellar ataxia and epilepsy, and her 9 asymptomatic relatives.

Main Outcome Measure  Genotype-phenotype correlation.

Results  Molecular testing on this patient showed an expansion of approximately 850 ATTCT repeats at the SCA10 locus. Similar SCA10 expansions of approximately 850 repeats were identified in 6 of 8 asymptomatic paternal relatives examined.

Conclusion  The stably transmitted pentanucleotide expansion of approximately 850 repeats may represent a mutant SCA10 allele with reduced penetrance that may express an early-onset, severe phenotype.


Author Affiliations: Genetika Laboratory, Alameda Augusto Stellfeld (Dr Raskin) and Neurology Service, Federal University of Paraná (Drs Teive, Arruda, and Werneck), Curitiba, Brazil; Department of Neurology, University of Texas Medical Branch, Galveston (Drs Ashizawa and Gao and Ms White); and Medical Genetics Laboratories, Baylor College of Medicine, Houston, Tex (Drs Fang and Roa).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.